In Vitro Diagnostic
Table of Contents
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing wi...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Shadi
+1 718 618 4897
ContraFect Corporation - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “ContraFect Corporation - Product Pipeline Review - 2013” provides data on the ContraFect ...
GeNeuro SA - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “GeNeuro SA - Product Pipeline Review - 2013” provides data on the GeNeuro SA's research and development ...
Summary Xhale, Inc. (Xhale) is a medical device company. The company develops non invasive medical devices for the diagnostic market. Its products include pharmaceutical supply chain integrity, therapeutic ...
... Was successfully commercialized in japan. 1961 Establishment of clinical laboratory division. Initiation of r&d of clinical diagnostics. 1969 Company name was changed to eiken chemical co., Ltd. In recognition ...
... Laboratory (r&d) automation is a steady growing market. molecular diagnostic market s trend clinical medical pss business field & strategy 7 products sales in business segment mid-term business plan ...
... In dna-based testing services for developmental disorders and cancer diagnostics, reported today that total revenues for the fourth quarter and twelve months ended december 31, 2013 increased to $1 ...
Reportlinker.com © Copyright 2014. All rights reserved.